Topalian SL - Search Results

1

Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates.

Brahmer JR, Drake CG, Wollner I, Powderly JD, Picus J, Sharfman WH, Stankevich E, Pons A, Salay TM, McMiller TL, Gilson MM, Wang C, Selby M, Taube JM, Anders R, Chen L, Korman AJ, Pardoll DM, Lowy I, Topalian SL. Brahmer JR, et al. Among authors: topalian sl. J Clin Oncol. 2010 Jul 1;28(19):3167-75. doi: 10.1200/JCO.2009.26.7609. Epub 2010 Jun 1. J Clin Oncol. 2010. PMID: 20516446 Free PMC article. Corrected and republished. Clinical Trial.

2

Intravenous administration of recombinant human macrophage colony-stimulating factor to patients with metastatic cancer: a phase I study.

Sanda MG, Yang JC, Topalian SL, Groves ES, Childs A, Belfort R Jr, de Smet MD, Schwartzentruber DJ, White DE, Lotze MT, et al. Sanda MG, et al. Among authors: topalian sl. J Clin Oncol. 1992 Oct;10(10):1643-9. doi: 10.1200/JCO.1992.10.10.1643. J Clin Oncol. 1992. PMID: 1403042 Clinical Trial.

3

The use of interleukin-2 and lymphokine-activated killer cells for the treatment of patients with non-Hodgkin's lymphoma.

Weber JS, Yang JC, Topalian SL, Schwartzentruber DJ, White DE, Rosenberg SA. Weber JS, et al. Among authors: topalian sl. J Clin Oncol. 1992 Jan;10(1):33-40. doi: 10.1200/JCO.1992.10.1.33. J Clin Oncol. 1992. PMID: 1727923

4

Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma.

Fisher B, Packard BS, Read EJ, Carrasquillo JA, Carter CS, Topalian SL, Yang JC, Yolles P, Larson SM, Rosenberg SA. Fisher B, et al. Among authors: topalian sl. J Clin Oncol. 1989 Feb;7(2):250-61. doi: 10.1200/JCO.1989.7.2.250. J Clin Oncol. 1989. PMID: 2644399 Clinical Trial.

5

Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study.

Topalian SL, Solomon D, Avis FP, Chang AE, Freerksen DL, Linehan WM, Lotze MT, Robertson CN, Seipp CA, Simon P, et al. Topalian SL, et al. J Clin Oncol. 1988 May;6(5):839-53. doi: 10.1200/JCO.1988.6.5.839. J Clin Oncol. 1988. PMID: 3259261

6

Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies.

Weber J, Yang JC, Topalian SL, Parkinson DR, Schwartzentruber DS, Ettinghausen SE, Gunn H, Mixon A, Kim H, Cole D, et al. Weber J, et al. Among authors: topalian sl. J Clin Oncol. 1993 Mar;11(3):499-506. doi: 10.1200/JCO.1993.11.3.499. J Clin Oncol. 1993. PMID: 7680375 Clinical Trial.

7

Renal dysfunction associated with the administration of high-dose interleukin-2 in 199 consecutive patients with metastatic melanoma or renal carcinoma.

Guleria AS, Yang JC, Topalian SL, Weber JS, Parkinson DR, MacFarlane MP, White RL, Steinberg SM, White DE, Einhorn JH, et al. Guleria AS, et al. Among authors: topalian sl. J Clin Oncol. 1994 Dec;12(12):2714-22. doi: 10.1200/JCO.1994.12.12.2714. J Clin Oncol. 1994. PMID: 7989949 Clinical Trial.

8

In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2.

Schwartzentruber DJ, Hom SS, Dadmarz R, White DE, Yannelli JR, Steinberg SM, Rosenberg SA, Topalian SL. Schwartzentruber DJ, et al. Among authors: topalian sl. J Clin Oncol. 1994 Jul;12(7):1475-83. doi: 10.1200/JCO.1994.12.7.1475. J Clin Oncol. 1994. PMID: 8021739

9

Randomized comparison of high-dose and low-dose intravenous interleukin-2 for the therapy of metastatic renal cell carcinoma: an interim report.

Yang JC, Topalian SL, Parkinson D, Schwartzentruber DJ, Weber JS, Ettinghausen SE, White DE, Steinberg SM, Cole DJ, Kim HI, et al. Yang JC, et al. Among authors: topalian sl. J Clin Oncol. 1994 Aug;12(8):1572-6. doi: 10.1200/JCO.1994.12.8.1572. J Clin Oncol. 1994. PMID: 8040669 Clinical Trial.

10

Infectious complications associated with interleukin-2 administration: a retrospective review of 935 treatment courses.

Pockaj BA, Topalian SL, Steinberg SM, White DE, Rosenberg SA. Pockaj BA, et al. Among authors: topalian sl. J Clin Oncol. 1993 Jan;11(1):136-47. doi: 10.1200/JCO.1993.11.1.136. J Clin Oncol. 1993. PMID: 8418224

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

183 results

Search Page